Dec 30, 2022 by Kody KesterWant Rising Dividend Income? This Stock Is a BuyWith more than a half century of dividend hikes, this consumer staple is a Dividend King.
Dec 29, 2022 by Kody KesterThis Unstoppable Stock Is a Clear Buy for Growth InvestorsCostco is a growth stock that should be able to thrive in any economic environment.
Dec 29, 2022 by Kody Kester2 Unstoppable Dividend Growth Stocks to Buy in 2023 and BeyondNothing is more reassuring to an income investor than a boost to the dividend.
Dec 26, 2022 by Kody KesterBuy This Warren Buffett-Owned Stock for 2023 and BeyondThis healthcare products distributor's business model can withstand a recession.
Dec 26, 2022 by Kody Kester3 Dividend Stocks That Should Pay You for the Rest of Your LifePassive income can be an investor's harbor in a sea of market volatility.
Dec 25, 2022 by Kody KesterIs This Monster Stock a Buy for Growth Investors?AutoZone could be partially shielded from a recession.
Dec 24, 2022 by Kody KesterThis Powerful Dividend-Paying Stock Hit Its 52-Week Low. Should You Buy Before 2022 Ends?This medtech company is among the most dominant in the world.
Dec 23, 2022 by Kody KesterThis Is My Top Ultra-High-Yield Dividend Stock to Buy Ahead of 2023According to analysts, this hospital REIT could soar more than 45% in 2023.
Dec 23, 2022 by Kody KesterLooking for a Fast-Growing Dividend Stock? Buy This Dominant RetailerThis discount retailer has delivered market-crushing returns over the last 10 years.
Dec 22, 2022 by Kody KesterIs This Growth Stock a Recession-Proof Buy?This discount store chain could help millions of customers stretch their budgets further through a recession.
Dec 22, 2022 by Kody KesterThe Top Healthcare Stocks to Buy With $100Healthcare is a sector that has proven to be reliable in recessions.
Dec 22, 2022 by Kody KesterHere's Why This Great Dividend Stock Is a BuyThis medical technology-focused stock offers income investors a 3.6% dividend yield.
Dec 20, 2022 by Kody KesterCould AstraZeneca's Asthma Drug Candidate Generate Billions?AstraZeneca's new asthma rescue treatment could soon be approved in the United States for adults.
Dec 17, 2022 by Kody KesterThis Powerful Dividend Growth Stock Could Keep Crushing the Market in 2023Analysts expect moderate upside from this health insurer in 2023.
Dec 16, 2022 by Kody KesterThis Red-Hot Growth Stock Is Ready to Roar in 2023 and BeyondAnalysts expect shares of this pet insurer to surge higher in 2023.
Dec 16, 2022 by Kody Kester2 Best Biotech Stocks to Buy Right NowDemand for medicines and vaccines has nowhere to go but up over the long run.
Dec 15, 2022 by Kody KesterWant Rising Passive Income? Buy This Blue Chip Dividend StockThis consumer staple's brands are loved by millions.
Dec 15, 2022 by Kody KesterThese High-Yield Dividend Stocks Are Growing at Blazing SpeedsThese real estate investment trusts yield 4.3% and 6.5%, respectively.
Dec 14, 2022 by Kody KesterShould You Ring the Register on This Bargain-Bin Retail Stock?This off-price apparel retailer crushed the market in 2022.
Dec 13, 2022 by Kody KesterBuy This Monster Stock Before It PopsIf a recession were to occur, Costco could be a solid defensive investment.
